Association between prostate specific membrane antigen imaging and initial treatment for prostate cancer among commercial insurance beneficiaries. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Omitting race and ethnicity from colorectal cancer (CRC) recurrence risk prediction models could decrease their accuracy and fairness, particularly for minority groups, potentially leading to ...

Machine Learning–Based Analysis of Treatment Sequences Typology in Advanced Non–Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab Deep convolutional neural networks were used to ...

Approximately 20% to 30% of men with prostate cancer experience disease recurrence within 5 years of therapeutic intervention. 1 A key challenge in managing these patients is a scarcity of accurate ...